Back to
Allworth Financial LP
QNCX
Showing 2 of 6 quarters
Position history for
Allworth Financial LP's holdings in QUINCE THERAPEUTICS INC
No. Allworth Financial exited its QNCX (Quince Therapeutics) position in Q1 2026. Its Q4 2025 13F listed 1,500 shares worth $5,025. Allworth Financial first reported QNCX in Q1 2023 and held it in 4 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$5,025
Total Shares Change
-1,500
Quarter-by-Quarter History